ArticleBMC cancer2026
Regional divergence in female cancer mortality in Brazil signals the unequal pace of the cancer transition.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe cancer transition framework describes the shift from infection-related cancers, such as cervical cancer, to cancers more commonly observed in high human development settings, such as breast cancer, as societies develop. Brazil, with marked regional disparities in health and socioeconomic indicators, offers a unique context to analyze how this transition unfolds unevenly across subnational regions. This study aimed to describe and compare levels and temporal trends in age-standardized mortality rates for breast and cervical cancer across Brazilian macroregions from 1980 to 2021, and to contextualize these patterns in relation to global Sociodemographic Index (SDI) group profiles.
methodsWe conducted an ecological analytical study with time series analysis of breast (C50) and cervical cancer (C53) mortality in Brazil from 1980 to 2021. Data were retrieved from the Global Burden of Disease (GBD) study, stratified by the five Brazilian macroregions and compared with global Sociodemographic Index (SDI) groups. We applied Joinpoint regression models to identify inflection points in mortality trends and estimated the Annual Percentage Change (APC) with 95% confidence intervals (CIs). Age-standardized mortality rates from GBD are presented with their corresponding 95% uncertainty intervals (UIs).
resultsBreast cancer mortality rates were highest in Brazil's Southeast (18.97 deaths/100,000) and South (18.20), with lower but rising rates in the North (11.08). Cervical cancer mortality was highest in the North (18.92) and lowest in the Southeast (9.83). Joinpoint regression revealed three trend periods for breast cancer (1980-1995, 1995-2014, 2014-2021) and two for cervical cancer (1980-1997, 1997-2021). While breast cancer mortality declined in the Southeast and South until mid-2010s and then rose again, the North and Northeast showed persistent increases. Cervical cancer mortality declined nationwide, but more slowly in the North and Northeast. Comparisons with SDI groups showed that the South and Southeast align with higher-SDI profiles, whereas the North and Northeast resemble lower-SDI groups.
conclusionsBreast and cervical cancer age-standardized mortality rates in Brazil follow divergent trajectories consistent with the cancer transition model, but regional inequalities shape their pace and intensity. While wealthier regions display mortality patterns consistent with contexts characterized by stronger health system capacity, as reported in the literature, less developed regions remain burdened by preventable cervical cancer and rising breast cancer mortality. Targeted, equity-oriented policies are essential to address structural disparities in prevention, screening, and treatment.
Indexed as
Identifiers
42919234What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.